A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

NCT07428616 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
100
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Exelixis